Success Stories: NIW and EB1-A Approvals Received for a Research Postdoc Fellow in Biomedical Science from China, Thanks to NAILG’s Team of Experts

Client’s Testimonial:

“Thanks for your help on my case!”

On May 4^th, 2022 and August 23^rd, 2022, we received another EB2-NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approval for a Research Postdoc Fellow in the Field of Biomedical Science (Approval Notice).

General Field: Biomedical Science

Position at the Time of Case Filing: Research Postdoc Fellow

Country of Origin: China

State of Residence at the Time of Filing: Texas

Approval Notice Date: May 4^th, 2022 (NIW) and August 23^rd, 2022 (EB-1A)

Processing Time: 3 months, 16 days (NIW) and 13 days (EB-1A) (Premium Processing Requested)

Case Summary:

“Cancer is one of the leading causes of death around the world, as it is responsible for approximately 10,000,000 global deaths on an annual basis. In addition, neurodegenerative diseases affect nearly 50,000,000 people worldwide. Further, these numbers are only expected to increase as the global population continues to grow in numbers and age. [Client’s] research is essential to accurately determine the mechanisms underpinning the development of these diseases. As a result, her work advances ongoing efforts in the field aimed at reducing the impact of cancer and neurodegenerative diseases in the United States and around the world.”

This is a section taken from a letter of support written by a recommending expert in the field of biomedical science for a postdoctoral fellow from China. She held a Ph.D. in biological sciences and had been working in the area for several years already, which had given her precious experience lending to her credibility as well.

She was one of the few leading disease genetics and cellular therapeutics experts in biomedical science, and she has achieved a consistent and notable record of success and influence in these areas of study. She is especially well-known for her work investigating stem cell-based cancer therapeutics and developing functional biomarkers for cancer treatment. The field has recognized her authority by inviting her to review and evaluate the work of her peers no fewer than 65 times.

She has also actively engaged her peers in the field of biomedical science by authoring and co-authoring 27 peer-reviewed articles and 1 provisional patent that have been published in international journals and have been cited 260 times in at least 33 countries according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of biomedical science.

These factors weighed in her favor when we prepared her case file for NIW (National Interest Waiver) and later her EB1-A (Alien of Extraordinary Ability) approval. We made sure that both of her petitions were customized and that they contained every necessary information that would be needed to prove their extraordinary ability or their worthiness for the United States. Once the petitions were ready, we were certain that they would not be rejected. So when first her NIW and later her EB1-A approvals came through, we felt proud of having worked with her on this case. We are glad that due to our work and the expedited plan of premium processing, her EB1-A could be approved in just 13 days.

Our team wishes her the best in future endeavors and thanks her for choosing our firm to represent her in these cases.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.